Publication details
Nové léky pro akutní srdeční selhání
| Title in English | New drugs for acute heart failure |
|---|---|
| Authors | |
| Year of publication | 2015 |
| Type | Article in Periodical |
| Magazine / Source | Kardiologická revue - Interní medicína |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | heart failure; serelaxin; ularititd; omecantiv; mortality |
| Description | The article describes clinical trials with new drugs tested for the treatment of acute heart failure. A large programme with vasodalatative drug serelaxin consists of three clinical trials REALAX II, RELAX repeat and RELAX paneurope. Human recombinant natriuretid peptide ulatitide is tested in clinical trial TURE HF. Differne machanism of action is expected from omecantiv mecaril, which is tested in the COSMIC programme. |